-
DE
Lung perfusion scintigraphy is a nuclear medicine imaging technique used to assess blood flow through the lungs. It is primarily performed to diagnose pulmonary embolism.
Lung perfusion scintigraphy is a nuclear medicine imaging technique used to assess blood flow through the lungs. It is primarily performed to diagnose pulmonary embolism.
Lung perfusion scintigraphy is a nuclear medicine imaging procedure that visualizes the distribution of blood flow (perfusion) within the lung tissue. A mildly radioactive substance -- known as a radiopharmaceutical -- is injected into the bloodstream and accumulates in the small blood vessels (capillaries) of the lungs. A special detection device called a gamma camera then records the emitted radiation and converts it into a detailed image.
The procedure shows which areas of the lungs are receiving adequate blood flow and where perfusion deficits exist. Lung perfusion scintigraphy is frequently combined with lung ventilation scintigraphy, which assesses airflow through the lungs. This combined approach is known as V/Q scintigraphy (ventilation-perfusion scintigraphy).
Lung perfusion scintigraphy is indicated in the following clinical situations:
No special preparation is generally required before the examination. The patient receives an intravenous injection of a solution containing tiny radioactively labeled protein particles called macroaggregated albumin (MAA). These particles are large enough to temporarily lodge in the pulmonary capillaries but small enough to pose no risk to the body.
The patient is then positioned beneath the gamma camera, which detects the emitted gamma rays and captures images of the lungs from multiple angles. The actual scan typically takes only a few minutes. In the combined V/Q scintigraphy, the patient also inhales a radioactively labeled gas or aerosol to visualize ventilation.
A nuclear medicine specialist analyzes the resulting images. Common findings include:
Interpretation is often guided by standardized criteria such as the PIOPED criteria (Prospective Investigation of Pulmonary Embolism Diagnosis), which categorize the probability of pulmonary embolism based on scan findings.
The radioactive substances used in lung perfusion scintigraphy have a very short half-life and are rapidly eliminated from the body. The effective radiation dose is relatively low and comparable to other diagnostic imaging procedures such as computed tomography (CT). Pregnant women should only undergo this procedure after careful consideration of the risks and benefits, as radiation exposure affects both the mother and the unborn child. However, in urgent cases, the procedure may still be performed during pregnancy, since untreated pulmonary embolism carries a high risk of serious complications.
Lung perfusion scintigraphy offers the following advantages:
The main limitation is that the procedure does not provide the same level of anatomical detail as CT pulmonary angiography (CTPA), which is currently the preferred method for diagnosing pulmonary embolism in many clinical settings. Nevertheless, V/Q scintigraphy remains a valuable alternative, particularly for specific patient groups.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.